Icenogle JP - Search Results

1

A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women.

Vernon SD, Reeves WC, Clancy KA, Laga M, St Louis M, Gary HE Jr, Ryder RW, Manoka AT, Icenogle JP. Vernon SD, et al. Among authors: icenogle jp. J Infect Dis. 1994 May;169(5):1108-12. doi: 10.1093/infdis/169.5.1108. J Infect Dis. 1994. PMID: 8169402

2

Genital papillomavirus infection and cervical dysplasia--opportunistic complications of HIV infection.

Laga M, Icenogle JP, Marsella R, Manoka AT, Nzila N, Ryder RW, Vermund SH, Heyward WL, Nelson A, Reeves WC. Laga M, et al. Among authors: icenogle jp. Int J Cancer. 1992 Jan 2;50(1):45-8. doi: 10.1002/ijc.2910500110. Int J Cancer. 1992. PMID: 1309459

3

Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia.

Icenogle JP, Laga M, Miller D, Manoka AT, Tucker RA, Reeves WC. Icenogle JP, et al. J Infect Dis. 1992 Dec;166(6):1210-6. doi: 10.1093/infdis/166.6.1210. J Infect Dis. 1992. PMID: 1331247

4

Human papillomavirus, human immunodeficiency virus, and cervical cancer: newly recognized associations?

Vernon SD, Icenogle JP, Johnson PR, Reeves WC. Vernon SD, et al. Among authors: icenogle jp. Infect Agents Dis. 1992 Dec;1(6):319-24. Infect Agents Dis. 1992. PMID: 1344670 Review.

5

Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16.

Icenogle JP, Sathya P, Miller DL, Tucker RA, Rawls WE. Icenogle JP, et al. Virology. 1991 Sep;184(1):101-7. doi: 10.1016/0042-6822(91)90826-w. Virology. 1991. PMID: 1651585

6

Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer.

Unger ER, Vernon SD, Thoms WW, Nisenbaum R, Spann CO, Horowitz IR, Icenogle JP, Reeves WC. Unger ER, et al. Among authors: icenogle jp. J Infect Dis. 1995 Nov;172(5):1184-90. doi: 10.1093/infdis/172.5.1184. J Infect Dis. 1995. PMID: 7594652

7

Divergent human papillomavirus type 16 variants are serologically cross-reactive.

Cheng G, Icenogle JP, Kirnbauer R, Hubbert NL, St Louis ME, Han C, Svare EI, Kjaer SK, Lowy DR, Schiller JT. Cheng G, et al. Among authors: icenogle jp. J Infect Dis. 1995 Dec;172(6):1584-7. doi: 10.1093/infdis/172.6.1584. J Infect Dis. 1995. PMID: 7594721

8

Risk factors for genital papillomavirus infection in populations at high and low risk for cervical cancer.

Reeves WC, Gary HE Jr, Johnson PR, Icenogle JP, Brenes MM, de Britton RM, Dobbins JG, Schmid DS. Reeves WC, et al. Among authors: icenogle jp. J Infect Dis. 1994 Oct;170(4):753-8. doi: 10.1093/infdis/170.4.753. J Infect Dis. 1994. PMID: 7930714

9

Cellular proteins involved in papillomavirus-induced transformation.

Swan DC, Vernon SD, Icenogle JP. Swan DC, et al. Among authors: icenogle jp. Arch Virol. 1994;138(1-2):105-15. doi: 10.1007/BF01310042. Arch Virol. 1994. PMID: 7980001 Review.

10

The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription.

Vernon SD, Hart CE, Reeves WC, Icenogle JP. Vernon SD, et al. Among authors: icenogle jp. Virus Res. 1993 Feb;27(2):133-45. doi: 10.1016/0168-1702(93)90077-z. Virus Res. 1993. PMID: 8384765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters